SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001564590-18-009659
Filing Date
2018-04-30
Accepted
2018-04-30 06:03:41
Documents
7
Period of Report
2018-06-13
Effectiveness Date
2018-04-30

Document Format Files

Seq Description Document Type Size
1 DEF 14A reta-def14a_20180613.htm DEF 14A 748142
2 GRAPHIC g2018042520174769218894.jpg GRAPHIC 6515
3 GRAPHIC g2018042520174767018893.jpg GRAPHIC 2518
4 GRAPHIC g2018042520175415118895.jpg GRAPHIC 69867
5 GRAPHIC g2018042520174766918892.jpg GRAPHIC 1206
6 GRAPHIC g2018042520174765418891.jpg GRAPHIC 6386
7 GRAPHIC g2018042520175417518896.jpg GRAPHIC 37122
  Complete submission text file 0001564590-18-009659.txt   920383
Mailing Address 2801 GATEWAY DRIVE SUITE 150 IRVING TX 75063
Business Address 2801 GATEWAY DRIVE SUITE 150 IRVING TX 75063 972-865-2206
REATA PHARMACEUTICALS INC (Filer) CIK: 0001358762 (see all company filings)

IRS No.: 113651945 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37785 | Film No.: 18786495
SIC: 2834 Pharmaceutical Preparations